CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-07-01 | BARBIER REMI CEO and Chairman of the Board | Sale | −11,692 | $5.42 | $63K | 6,109,755 |
| 2010-06-16 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise | +1,500 | $4.40 | $7K | 49,687 |
| 2010-06-16 | SCHOENHARD GRANT Chief Scientific Officer | Sale | −1,500 | $5.45 | $8K | 48,187 |
| 2010-06-16 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | −1,500 | $4.40 | $7K | 655,500 |
| 2010-06-03 | BARBIER REMI CEO and Chairman of Board | Sale | −8,238 | $5.53 | $46K | 6,121,447 |
| 2010-06-02 | BARBIER REMI CEO and Chairman of Board | Sale | −14,089 | $5.54 | $78K | 6,129,685 |
| 2010-06-01 | BARBIER REMI CEO and Chairman of Board | Sale | −27,673 | $5.52 | $153K | 6,143,774 |
| 2010-05-27 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise | +10,979 | $5.25 | $58K | 59,166 |
| 2010-05-27 | SCHOENHARD GRANT Chief Scientific Officer | Sale | −10,979 | $5.74 | $63K | 48,187 |
| 2010-05-27 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | −10,979 | $5.25 | $58K | 657,000 |
| 2010-05-20 | ROBERTSON SANFORD Director | Grant or award · Non-Qualified Stock Options | +25,000 | $5.60 | $140K | 355,000 |
| 2010-05-20 | O DONNELL MICHAEL J Director | Grant or award · Non-Qualified Stock Option | +25,000 | $5.60 | $140K | 275,000 |
| 2010-05-20 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualified Stock Options | +25,000 | $5.60 | $140K | 330,000 |
| 2010-05-19 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise | +2,486 | $5.25 | $13K | 50,673 |
| 2010-05-19 | SCHOENHARD GRANT Chief Scientific Officer | Sale | −2,486 | $5.77 | $14K | 48,187 |
| 2010-05-19 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | +2,486 | $5.25 | $13K | 667,979 |
| 2010-05-18 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise | +7,926 | $5.25 | $42K | 61,222 |
| 2010-05-18 | SCHOENHARD GRANT Chief Scientific Officer | Sale | −7,926 | $5.78 | $46K | 48,187 |
| 2010-05-18 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | +7,926 | $5.25 | $42K | 670,465 |
| 2010-05-17 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise | +1,500 | $4.40 | $7K | 49,687 |
Page 23 of 25 · 498 trades